Literature DB >> 11440121

Production of humanized antibody against human high-affinity IgE receptor in a serum-free culture of CHO cells, and purification of the Fab fragments.

T Takai1, K Takahashi, M Akagawa-Chihara, M Fukada, T Yuuki, I Shibuya, K Okumura, C Ra, T Yokota, Y Okumura.   

Abstract

We describe the preparation of Fab fragments of a humanized anti-human high-affinity IgE receptor (Fc epsilonRIalpha) antibody potentially useful for treatment of IgE-mediated allergic diseases. IgE-binding capacities of sixteen combinations of light and heavy chains of four recombinant anti-Fc epsilonRIalpha antibodies, chimeric CRA2, humanized CRA2, chimeric CRA4, and humanized CRA4, were compared. A combination in which both chains were of humanized CRA2 had the highest activity. Stable transfectant clones of four kinds of host cells expressing recombinant antibodies were established. CHO-K1 cells were the most productive. Serum-free media suitable for culture of the stable CHO-transfectant clones were screened. The concentration of the humanized CRA2, which the most productive clone secreted into the chosen serum-free medium, was approximately 100 microg/ml. A procedure for the purification of the antibody, papain-digestion, and purification of Fab fragments was established. The highly purified humanized Fab fragments are suitable for use to examine their in vivo activity and immunogenicity in primates.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11440121     DOI: 10.1271/bbb.65.1082

Source DB:  PubMed          Journal:  Biosci Biotechnol Biochem        ISSN: 0916-8451            Impact factor:   2.043


  3 in total

1.  Carboplatin-induced severe hypersensitivity reaction: role of IgE-dependent basophil activation and FcεRI.

Authors:  Takuya Iwamoto; Hiroyuki Hirai; Nozomi Yamaguchi; Natsuki Kobayashi; Hiroko Sugimoto; Tsutomu Tabata; Masahiro Okuda
Journal:  Cancer Sci       Date:  2014-11-05       Impact factor: 6.716

Review 2.  Omalizumab and IgE in the Control of Severe Allergic Asthma.

Authors:  Yasuhiro Gon; Shuichiro Maruoka; Kenji Mizumura
Journal:  Front Pharmacol       Date:  2022-03-10       Impact factor: 5.810

3.  A novel approach to predict cetuximab-induced hypersensitivity reaction: detection of drug-specific IgE on basophils.

Authors:  Takuya Iwamoto; Akiharu Okamoto; Hajime Ishinaga; Kasumi Shimizu; Alberto A Gayle; Naoya Arai; Kazuhiko Takeuchi; Masahiro Okuda
Journal:  Cancer Med       Date:  2016-02-16       Impact factor: 4.452

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.